Scope of the Role This pivotal global role within the Global Value & Market Access team is responsible for shaping global market access, pricing, evidence‐generation, and health policy strategies for Alfasigma's specialty and rare disease portfolio. The position drives the development of compelling value propositions and evidence plans that support optimal pricing, reimbursement, and patient access outcomes across key global markets. Working in close partnership with the SVP Global Value & Market Access and cross‐functional stakeholders, the role integrates payer, Health Technology Assessment (HTA), and health policy perspectives into asset strategy and lifecycle planning. The role offers a unique opportunity to influence asset value maximization, portfolio strategy, shape access decisions from early development through launch, and contribute to Alfasigma's leadership in rare diseases and orphan drugs. What will you do 1. Lead Global Market Access, Pricing and Health Policy Strategy Define and execute global access, pricing, value, and health policy strategies.



Develop value propositions aligned with unmet needs and business priorities. Integrate payer, HTA, healthcare system, and policy insights into decision‐making. Anticipate evolving access and policy landscapes across key markets. Optimize pricing, access, and sustainable patient access opportunities. 2. Drive Evidence Generation and Value Demonstration Define evidence needs for payers, HTA bodies, and policymakers. Partner cross‐functionally to align evidence with access objectives. Lead generation of clinical, economic, real‐world, and patient‐centered evidence. Ensure value packages meet stakeholder needs. Support lifecycle strategies to strengthen access and reimbursement outcomes. 3. Develop Global Access Tools and HTA Support Materials Lead development of global value dossiers, payer tools, and access plans. Prepare evidence packages for HTA, reimbursement, and value communication. Oversee health economic

📌 Director, global value (Italia)
🏢 Alfasigma
📍 Italia